Hackensack Meridian Health officially opened its Institute for Multiple Myeloma to help combat the rare bone marrow cancer.
“This new center takes us a quantum leap forward in the fight against Multiple Myeloma and related illnesses,’’ said Robert C. Garrett, co-CEO of HMH, in a statement. “This helps us achieve something that has been elusive – curing significant numbers of patients.’’
The Institute for Multiple Myeloma, which opened Monday, is part of the HMH Center for Discovery and Innovation situated in Nutley and Clifton at the HMH Interprofessional Health Sciences Campus alongside the Hackensack Meridian School of Medicine at Seton Hall University.
Dr. David Siegel, chief of the Multiple Myeloma Division at John Theurer Cancer Center at Hackensack University Medical Center, is leading the institute. JTCC has built one of the largest multiple myeloma programs in the world, currently treating 2,000 patients.
“We seek to transform the treatment of patients with multiple myeloma by integrating our extensive clinical expertise and research contributions with ongoing basic and translational research,’’ Siegel said in a statement.